Landscapes / Companies
Immedica Pharma AB not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 3 in all
Trials
1 active
9 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Neuroactive steroid gamma-aminobutyric acid A receptor positive modulator |
Approved | Dec 2029Phase 3 trial completes | |||
| Next date | Dec 2029 · Phase 3 trial completes | ||||
| Also tested for | CDKL5 Deficiency Disorder | ||||
| Open drug page | |||||
About
- No active trial
- Chronocort, Pegzilarginase
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021